Financials
- Market Capitalization 103.64 M
- Employee 25
- Founded 2013
- CEO Ankit Mahadevia
- Website www.sperotherapeutics.com
- Headquarter Delaware, United States
- FIGI BBG00HXSJ1R2
- Industry Biotecnologia
Ricavi totali
Utile netto
Utile base per azione (EPS base)
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti
Rapporto prezzo/utili
8.67
Rapporto prezzo/fatturato
2.22
Related tickers
| # | Nome | Prezzo | 24h % | 7d % | 1M % | 1Y % | Valore di Mercato | Ultimi 7 Giorni | |
|---|---|---|---|---|---|---|---|---|---|
| 3960 | KLRS Kalaris Therapeutics, Inc. - Common Stock | 4.49 USD | +1.58% | -4.06% | -1.10% | -56.11% | 106.83 M USD | ||
| 3973 | VRCA Verrica Pharmaceuticals Inc. - Common Stock | 6.05 USD | +2.20% | -0.66% | +4.31% | +0.50% | 103.93 M USD | ||
| 3981 | NTHI NeOnc Technologies Holdings, Inc. - Common Stock | 3.92 USD | -9.26% | -9.47% | -18.33% | -55.28% | 101.97 M USD | ||
| 3994 | ENLV Enlivex Ltd. - Ordinary Shares | 6.23 USD | -6.60% | +1146.00% | +777.46% | +394.44% | 98.59 M USD |